Biotech and Pharmaceuticals Pharmaceuticals

  • Activist investor Starboard Value LP in April called on Depomed to explore a sale after disclosing a stake of close to 10 percent. The ruling prevents Actavis, Alkem Laboratories Ltd and Roxane Laboratories Inc from selling generic versions of Nucynta until 2025, the company said. Sales of Nucynta, which Depomed acquired in early 2015 from Janssen...

  • Sept 30- Depomed Inc said a court ruled in favor of the drug maker in a patent litigation over its opioid drug, Nucynta, extending its market exclusivity until 2025.. The ruling comes weeks after sources told Reuters that Depomed's talks with potential buyers are expected to start shortly after the court decided on Nucynta, the company's biggest drug.

  • SAN JUAN, Puerto Rico— The former CEO of an international pharmaceutical company was indicted Friday in a more than $100 million fraud scheme that authorities say led to the collapse of one of Puerto Rico's largest banks. The U.S. Justice Department said Jack Kachkar faces eight counts of wire fraud from his time as chairman and CEO of Inyx Inc. from 2005 to 2007..

  • Dr. Julie C. Brown, a University of Washington School of Medicine pediatric emergency physician, holding two EpiPens, the new design at left and the old at right.

    Mylan CEO testified before a House panel that EpiPen prices went up because of investing upgrades, according to NBC.

  • Health care industry in flux but improving: Cleveland Clinic CEO

    Dr. Toby Cosgrove, Cleveland Clinic CEO, grades the nation's health care industry. Access and supply are big issues, says Cosgrove.

  • Reining in rising costs of drugs: Cleveland Clinic CEO

    The question is what is profit margin, says Dr. Toby Cosgrove, Cleveland Clinic CEO, talking about pharmaceutical companies and the difference between making a profit and charging a premium.

  • Why insurers are fleeing heath care exchanges: Expert

    Dr. Toby Cosgrove, Cleveland Clinic CEO, explains why the health care exchanges have not been very successful and what's driving up the cost of health care.

  • Trouble ahead for Teva?

    Discussing why options traders are cautious about Teva Pharmaceuticals with CNBC contributor Mike Khouw.

  • NEW YORK— U.S. stocks skidded Thursday as drug companies and banks absorbed large losses. Drugmakers faced scrutiny over price increases, while banks fell as investors worried about the stability of Deutsche Bank and other financial institutions. The Dow Jones industrial average slid 195.79 points, or 1.1 percent, to 18,143.45.

  • Representative Elijah Cummings, a Democrat from Maryland, left, holds Mylan NV EpiPen medication while making an opening statement next to Representative Jason Chaffetz, a Republican from Utah and chairman of the House Oversight and Government Reform Committee, during a House Oversight and Government Reform Committee hearing in Washington, D.C.

    Lawmakers are venting outrage over high prescription drug costs, but members might want to look in the mirror, NBC News reports.

  • Tom Frieden, M.D., M.P.H., director of the Centers for Disease Control and Prevention, kicks off the 2016-2017 flu season by getting vaccinated at the National Foundation for Infectious Diseases news conference. In revealing the latest U.S. flu vaccine coverage, he noted a measurable drop among those 50 years and older, asking “if 9 out of 10 doctors are getting a flu vaccine, why aren’t you?”

    Older people are more at risk for the flu, but officials say everyone older than 6 months should get vaccinated.

  • *OPEC deal boosts energy shares, drugmakers down. LONDON, Sept 29 (Reuters)- European shares ended flat on Thursday as losses among drugmakers offset energy share gains following an OPEC deal to cut output, while Commerzbank slid after the German lender froze dividend payments. Ronny Claeys, senior strategist at KBC Asset Management, said the OPEC agreement was...

  • Sept 29- Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines. Express Scripts, the largest manager of U.S. drug benefits, in November sued Horizon for a breach of contract, seeking $166.2 million in rebates related to Duexis, Rayos and...

  • Stocks are ending lower on Wall Street, led by drops in drugmakers and banks. Banks fell as worries grew about Deutsche Bank, Germany's biggest lender. Stocks are moving slightly lower in midday trading on Wall Street as declines in health care and high-dividend companies offset gains in consumer goods companies.

  • Sept 29- Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines. Express Scripts, the largest manager of U.S. drug benefits, in November sued Horizon for a breach of contract, seeking $166.2 million in rebates related to Duexis, Rayos and...

  • Americans want government to tackle drug price hikes

    A new survey shows a majority of Americans believe prescription drug costs are unreasonable.

  • In the last 13 years, Congress passed major legislation that expanded taxpayer-financed coverage for prescription drugs but lacked explicit mechanisms for dealing with costs, instead relying mainly on market forces. Congress "inadvertently created a situation where price increases are much more rapid," said economist Paul Ginsburg, a Medicare expert who...

  • COPENHAGEN, Denmark— Danish drug maker Novo Nordisk says it plans to lay off some 1,000 employees globally to reduce operating costs because of "a challenging competitive environment, especially in its large U.S. market." Copenhagen- based Novo Nordisk said Thursday the layoffs will affect its research and development departments, headquarters staff...

  • Drugmakers faced scrutiny over price increases, while banks fell as investors worried about the stability of Deutsche Bank and other financial institutions. Quincy Krosby, market strategist for Prudential Financial, said investors don't trust Deutsche Bank's statements about its financial health and they are worried what will happen to the bank and to...

  • *Medak in southern India is major center for cheap antibiotics. Now, even the poorest villagers here in India's baking south point to the barren banks and frothy water and say they avoid going anywhere near it. A short drive from the bustling tech hub of Hyderabad, Medak is the heart of India's antibiotics manufacturing business: a district of about 2.5 million...